Pyoderma gangrenosum: A retrospective review of patient characteristics, comorbidities and therapy in 103 patients

British Journal of Dermatology

Volumn 165, Issue 6, 2011, Pages 1244-1250

  Binus, A M ^a   Qureshi, A A ^a   Li, V W ^a   Winterfield, L S ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; CALCINEURIN INHIBITOR; CYCLOSPORIN A; DAPSONE; DOXYCYCLINE; ETANERCEPT; IMMUNOGLOBULIN; INFLIXIMAB; MINOCYCLINE; MYCOPHENOLIC ACID; PIMECROLIMUS; STEROID; TACROLIMUS; THALIDOMIDE;

ARTHRITIS; CLINICAL FEATURE; COMORBIDITY; DEBRIDEMENT; DEMOGRAPHY; ENTERITIS; EPIDEMIOLOGICAL DATA; HEMATOLOGIC DISEASE; HEPATITIS; HUMAN; MAJOR DEPRESSION; MORTALITY; PRIORITY JOURNAL; PSORIASIS; PYODERMA GANGRENOSUM; RETROSPECTIVE STUDY; REVIEW; SEX DIFFERENCE; SKIN BIOPSY; SKIN GRAFT;

ADULT; AGED; AGED, 80 AND OVER; COMORBIDITY; DERMATOLOGIC AGENTS; FEMALE; HUMANS; MALE; MASSACHUSETTS; MIDDLE AGED; PYODERMA GANGRENOSUM; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 82255164078     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2011.10565.x     Document Type: Review

References (27)

1. Brunsting LA, Goeckerman WH, O'Leary PA,. Pyoderma (ecthyma) gangrenosum: clinical and experimental observations in five cases occurring in adults. Arch Dermatol Syphilol 1930; 22: 655-80.
2. Powell FC, Schroeter AL, Su WP, et al. Pyoderma gangrenosum: a review of 86 patients. Q J Med 1985; 55: 173-86. (Pubitemid 15047362)
3. Weenig RH, Davis MD, Dahl PR, et al. Skin ulcers misdiagnosed as pyoderma gangrenosum. N Engl J Med 2002; 347: 1412-18. (Pubitemid 35239713)
4. von den Driesch P,. Pyoderma gangrenosum: a report of 44 cases with follow-up. Br J Dermatol 1997; 137: 1000-5. (Pubitemid 28011148)
5. Crowson AN, Mihm MC Jr, Magro C,. Pyoderma gangrenosum: a review. J Cutan Pathol 2003; 30: 97-107. (Pubitemid 36384853)
6. Reichrath J, Bens G, Bonowitz A, et al. Treatment recommendations for pyoderma gangrenosum: an evidence-based review of the literature based on more than 350 patients. J Am Acad Dermatol 2005; 53: 273-83. (Pubitemid 40979585)
7. Wollina U,. Clinical management of pyoderma gangrenosum. Am J Clin Dermatol 2002; 3: 149-58. (Pubitemid 34533775)
8. Powell FC, Schroeter AL, Su WP, et al. Pyoderma gangrenosum and monoclonal gammopathy. Arch Dermatol 1983; 119: 468-72. (Pubitemid 13100109)
9. Hasselmann DO, Bens G, Tilgen W, et al. Pyoderma gangrenosum: clinical presentation and outcome in 18 cases and review of the literature. J Dtsch Dermatol Ges 2007; 5: 560-4. (Pubitemid 47047222)
10. Bennett ML, Jackson JM, Jorizzo JL, et al. Pyoderma gangrenosum. A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions. Medicine (Baltimore) 2000; 79: 37-46. (Pubitemid 30077735)
11. Shammas NW,. Epidemiology, classification, and modifiable risk factors of peripheral arterial disease. Vasc Health Risk Manag 2007; 3: 229-34. (Pubitemid 46860711)
12. Mancini GJ, Floyd L, Solla JA,. Parastomal pyoderma gangrenosum: a case report and literature review. Am Surg 2002; 68: 824-6. (Pubitemid 44971211)
13. Sapienza MS, Cohen S, Dimarino AJ,. Treatment of pyoderma gangrenosum with infliximab in Crohn's disease. Dig Dis Sci 2004; 49: 1454-7. (Pubitemid 39273621)
14. Sheldon DG, Sawchuk LL, Kozarek RA, et al. Twenty cases of peristomal pyoderma gangrenosum: diagnostic implications and management. Arch Surg 2000; 135: 564-8.
15. Lyon CC, Smith AJ, Beck MH, et al. Parastomal pyoderma gangrenosum: clinical features and management. J Am Acad Dermatol 2000; 42: 992-1002. (Pubitemid 30368667)
16. Callen JP,. Pyoderma gangrenosum. Lancet 1998; 351: 581-5. (Pubitemid 28077573)
17. Blitz NM, Rudikoff D,. Pyoderma gangrenosum. Mt Sinai J Med 2001; 68: 287-97. (Pubitemid 32717824)
18. Keane FM, MacFarlane CS, Munn SE, et al. Pyoderma gangrenosum and hepatitis C virus infection. Br J Dermatol 1998; 139: 924-5. (Pubitemid 28520314)
19. Byrne JP, Hewitt M, Summerly R,. Pyoderma gangrenosum associated with active chronic hepatitis: report of two cases. Arch Dermatol 1976; 112: 1297-301.
20. Marshall AW, Slonim JM, Smallwood RA, et al. The association of chronic active hepatitis with pyoderma gangrenosum. Aust N Z J Med 1978; 8: 656-8. (Pubitemid 9132535)
21. Green LK, Hebert AA, Jorizzo JL, et al. Pyoderma gangrenosum and chronic persistent hepatitis. J Am Acad Dermatol 1985; 13: 892-7. (Pubitemid 16228639)
22. Yurci A, Guven K, Torun E, et al. Pyoderma gangrenosum and exacerbation of psoriasis resulting from pegylated interferon alpha and ribavirin treatment of chronic hepatitis C. Eur J Gastroenterol Hepatol 2007; 19: 811-15. (Pubitemid 47266713)
23. Stichenwirth M, Riedl E, Pehamberger H, et al. Pyoderma gangrenosum in a patient with seronegative rheumatoid arthritis during therapy with adalimumab: toxic effects of adalimumab or failure of adalimumab to prevent the onset of this phenomenon? Arch Dermatol 2008; 144: 817-18. (Pubitemid 351846899)
24. Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003; 289: 3095-105. (Pubitemid 37432885)
25. Findley P, Shen C, Sambamoorthi U,. Multimorbidity and persistent depression among veterans with diabetes, heart disease, and hypertension. Health Soc Work 2011; 36: 109-19.
26. Katon WJ,. Epidemiology and treatment of depression in patients with chronic medical illness. Dialogues Clin Neurosci 2011; 13: 7-23.
27. Miller J, Yentzer BA, Clark A, et al. Pyoderma gangrenosum: a review and update on new therapies. J Am Acad Dermatol 2010; 62: 646-54.